Welcome back to Cover to Cover: Medical Schemes Explained, a column in partnership with Medihelp, helping financial advisers to break down the complexities of medical schemes, so clients can make informed decisions.
Read the earlier editions of Cover to Cover on decoding medical scheme plans, Prescribed Minimum Benefits (PMBs), waiting periods, medical scheme dependants, co-payments, and how to maximise medical savings.
In this edition, we examine medical schemes versus medical insurance – and what financial advisers need to clarify before recommending either option.
In today’s cost-constrained environment, more South Africans are asking: Why pay more for medical scheme cover when medical insurance is cheaper?
For financial advisers, the answer requires more than a comparison of monthly premiums. It requires a clear understanding of structural differences, regulatory protections, underwriting implications, and long-term risk exposure.
Medical schemes and medical insurance products are not interchangeable. Advisers who treat them as such risk exposing clients – and themselves – to unintended consequences.
Below is a practical framework to guide responsible advice.
The structural difference: Social protection vs risk insurance
Medical schemes are governed by the Medical Schemes Act and regulated by the Council for Medical Schemes. They are non-profit, community-rated, and must provide Prescribed Minimum Benefits (PMBs).
Medical insurance products are governed under insurance legislation and regulated by the Financial Sector Conduct Authority and the Prudential Authority. They are risk-rated, for-profit insurance contracts and are not required to provide PMBs.
This distinction is fundamental.
- Medical schemes provide guaranteed minimum healthcare protection, particularly for life-threatening and chronic conditions.
- Medical insurance provides defined, capped benefits subject to underwriting.
Advisers must ensure clients understand that these are structurally different risk solutions.
The PMB factor: Why it changes the value equation
PMBs require medical schemes to cover:
- Emergency medical treatment;
- 270+ specified conditions;
- 26 chronic disease list conditions; and
- Ongoing treatment and care for these conditions.
Importantly, PMBs cannot be subject to overall annual caps.
Medical insurance policies, by contrast, may:
- Cap benefits per event or per year;
- Exclude chronic conditions;
- Limit oncology or specialist treatment; and
- Restrict hospital benefits to fixed rand amounts.
In a catastrophic health event – such as cancer, organ failure, or major trauma – the difference between capped insurance and regulated PMB protection can be financially life-altering.
Underwriting and access
Medical schemes:
- Cannot refuse membership based on health;
- Cannot charge risk-based premiums;
- May impose waiting periods (three-month general; 12-month condition-specific); and
- May apply late-joiner penalties for those over 35 without prior scheme membership.
Medical insurance:
- Can decline applications;
- Can exclude pre-existing conditions permanently;
- Can load premiums; and
- May cancel or amend cover based on underwriting terms.
Advisers must clearly communicate that medical insurance is individually underwritten risk cover – not guaranteed access to healthcare funding.
Switching risks: a commonly overlooked pitfall
One of the most misunderstood areas is switching.
Time spent on medical insurance does not count as prior medical scheme membership.
This means:
- Waiting periods may apply when joining a scheme later;
- Late-joiner penalties may apply; and
- Condition-specific exclusions may apply.
Clients who downgrade from a scheme to insurance may find it significantly more expensive – and restrictive – to return years later. This long-term consequence must be explicitly discussed and documented.
When medical insurance may be appropriate
There are situations where medical insurance may serve a role:
- Younger, healthy individuals with limited budgets.
- Defined accident or hospital-event cover needs.
- Short-term affordability constraints.
However, it should not be positioned as a like-for-like alternative to comprehensive medical scheme protection. Suitability is key.
Cost vs value: The adviser’s real role
Premium comparison is the easiest conversation. Risk exposure is the most important one.
Advisers should help clients evaluate:
- Catastrophic illness scenarios;
- Chronic disease probability;
- Long-term affordability;
- Late-joiner penalty implications;
- Medical inflation trends; and
- Out-of-pocket exposure under capped benefits.
A lower premium today may translate into significantly higher financial risk tomorrow.
Three questions every adviser should ask
Before recommending either option, advisers should ask:
- If the client were diagnosed with a serious illness tomorrow, how would this product respond?
- Is the client comfortable with benefit caps and exclusions?
- Is the client’s priority affordability now, or guaranteed protection over the long term?
The answers will usually clarify suitability.
Essential disclosure for client protection
To meet FAIS obligations and ensure informed consent, advisers must clearly explain:
- Medical insurance is not a medical scheme.
- It does not provide PMBs.
- Benefits are capped and subject to underwriting.
- Switching later may trigger penalties or waiting periods.
- Chronic and catastrophic cover differs materially.
These distinctions should be recorded in the Record of Advice.
Final thought: Advice must be risk-based, not premium-based
Healthcare funding is not simply another short-term insurance decision. It is a long-term risk management strategy tied directly to financial security.
Medical schemes and medical insurance products both have roles to play, but they serve different purposes.
Advisers who take the time to explain these differences clearly not only protect their clients but also strengthen trust in the advice profession itself.
